Skip to main content
. 2017 Jun 27;8(47):81880–81891. doi: 10.18632/oncotarget.18737

Figure 1. Characterization of 3T3-EXO and 3T3-A-EXO.

Figure 1

(A) Assessment of size distribution of 3T3-EXO and 3T3-A-EXO by nanoparticle tracking analysis technology. (B) Morphology of 3T3-EXO and 3T3-A-EXO under electron microscopy. Scale bar = 100 nm. (C) Western blot detection of Calnexin, GRP94, Alix, CD63 and TSG101 in 3T3-EXO and 3T3-A-EXO. The data are representative of three independent experiments.